Folprecht, G., Pericay, C., Saunders, M., Thomas, A., Lopez, R., Roh, J., . . . Zalcberg, J. (2016). Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study.
Citación estilo ChicagoFolprecht, G., et al. Oxaliplatin and 5-FU/folinic Acid (modified FOLFOX6) With or Without Aflibercept in First-line Treatment of Patients With Metastatic Colorectal Cancer: The AFFIRM Study. 2016.
Cita MLAFolprecht, G., et al. Oxaliplatin and 5-FU/folinic Acid (modified FOLFOX6) With or Without Aflibercept in First-line Treatment of Patients With Metastatic Colorectal Cancer: The AFFIRM Study. 2016.
Precaución: Estas citas no son 100% exactas.